| Literature DB >> 21695711 |
Maria Teresa Rubino1, Dariana Maggi, Antonio Laghezza, Fulvio Loiodice, Paolo Tortorella.
Abstract
In the last 20 years, a great variety of synthetic, low molecular weight MMP inhibitors (MMPIs) have been synthesized and tested, although none has reached clinical utility. Exploration of novel ZBGs and development of non-hydroxamate MMPI has become a focus in current research. It's well-known that polyphenols can produce beneficial effects on human health by their antioxidant properties as well as they have the ability to block gelatinase activity. In this work we tested a series of selected phenols as MMP inhibitors. The most interesting hit (B6) shows sub-micromolar activity against MMP-2 (IC(50) 0.59 ± 0.05 µM, LE = 1.07) and a fairly good selectivity spectrum.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21695711 DOI: 10.1002/ardp.201000350
Source DB: PubMed Journal: Arch Pharm (Weinheim) ISSN: 0365-6233 Impact factor: 3.751